| Gene | Score gda | Association Type | Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.010 | Biomarker | disease | BEFREE | The residence time performed well to predict microemboli (C-index = 0.89, 95% CI, 0.75-1.00) and closely correlated with the number of HITS (R = 0.87, P < .001). | 31813676 | 2020 | ||||
|
0.010 | Biomarker | disease | BEFREE | Both minimally invasive extracorporeal circulation systems assessed in this study, the LivaNova Inspire Min.I and the Getinge minimized extracorporeal circulation, showed comparable air removal properties, after both bolus and gaseous microemboli air challenges. | 30915891 | 2019 | ||||
|
0.010 | Biomarker | disease | BEFREE | Evaluation of incidence, significance, and prognostic role of circulating tumor microemboli and transforming growth factor-β receptor I in head and neck cancer. | 28815787 | 2017 | ||||
|
0.010 | AlteredExpression | disease | BEFREE | We showed that reduced expression of either miR-125b or miR-100 in human HCC tissues was significantly associated with the presence of VETC, venous invasion of tumour cells, and the occurrence of endothelium-coated microemboli. | 27577856 | 2016 | ||||
|
0.010 | Biomarker | disease | BEFREE | Significantly more MMP-9- and GFAP-positive cells were detected in the transgenic groups (P<0.001), particularly in the transgenic microemboli group. | 24962158 | 2014 | ||||
|
0.010 | Biomarker | disease | BEFREE | The mice were divided into a wild-type sham surgery group (n = 15), a wild-type coupled with microemboli group (n =15), an APP/PS1 double transgenic sham surgery group (n =15) and an APP/PS1 double transgenic coupled with microemboli group (n =15). | 24962158 | 2014 | ||||
|
0.010 | Biomarker | disease | BEFREE | Significantly more MMP-9- and GFAP-positive cells were detected in the transgenic groups (P<0.001), particularly in the transgenic microemboli group. | 24962158 | 2014 |